MEDIROM Healthcare Technologies Inc.
MRM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $8 | $7 | $7 | $5 |
| % Growth | 21.5% | -1.8% | 28.5% | – |
| Cost of Goods Sold | $6 | $5 | $5 | $4 |
| Gross Profit | $2 | $2 | $2 | $1 |
| % Margin | 27.1% | 23% | 27.4% | 26.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -0.2% | -5.7% | 1.4% | -8.7% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $0 | $0 | $0 | -$0 |
| Tax Expense | -$0 | -$0 | $0 | $1 |
| Net Income | $0 | $0 | $0 | -$1 |
| % Margin | 1.8% | 1.7% | 2.1% | -18.3% |
| EPS | 29.13 | 23.64 | 30.54 | -203.13 |
| % Growth | 23.2% | -22.6% | 115% | – |
| EPS Diluted | 28.52 | 22.27 | 27.23 | -203.13 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 4.7% | 4.5% | 5.4% | -5.1% |